Skip to content

An Electronic Shared Decision-Making Application to Improve Asthma Outcomes

An Electronic Shared Decision-Making Application to Improve Asthma Outcomes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04951102
Enrollment
81
Registered
2021-07-06
Start date
2021-03-03
Completion date
2022-09-14
Last updated
2022-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

Asthma, Shared Decision Making, SDM

Brief summary

This study will increase knowledge about the feasibility and effect on patient satisfaction and clinical outcomes of using an electronic Shared Decision Making (SDM) application (app) for patients with asthma in the allergy/immunology clinic visit setting. SDM is defined as an approach where clinicians and patients share the best available evidence when faced with the task of making decisions, and where patients are supported to consider options and make informed choices.

Interventions

BEHAVIORALElectronic Asthma Shared Decision-Making App

The electronic Asthma SDM App will ask questions related to medicine-related, non-medicine-related, and COVID-19-related concerns about patients' asthma, the patients' personal goals for asthma control and expectation for their upcoming visit, and the patients' preferred level of details and involvement in coming to a decision about their asthma treatment. They may also use the Asthma SDM app to find information about asthma, medication management, COVID-19 and COVID-19 vaccines.

BEHAVIORALShared Decision Making Physician Training Video

Training video to educate physicians on Shared Decision-Making and the use of Shared Decision-Making tools.

BEHAVIORALElectronic Asthma Shared Decision-Making App- Patient Data

Data from the pre-visit electronic Asthma SDM app completed by the patients. Data includes medicine-related, non-medicine-related, and COVID-related concerns about patients' asthma, the patients' personal goals for asthma control and expectation for their upcoming visit, and the patients' preferred level of details and involvement in coming to a decision about their asthma treatment.

BEHAVIORALStandard Care

Standard Care for asthma.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

The subjects will be clustered in 2 groups of patients and physicians based on participating health care provider and clinic location. Group A will be the intervention group and Group B will be the control group.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* English speaking * Diagnosis of persistent asthma * Have an in-person visit or telehealth encounter at the allergy/clinical immunology clinics participating in this study

Exclusion criteria

* Diagnosis of intermittent asthma * Any other lung disease * Smoking greater than 20 pack years or current smoking * Mental impairment such that participation would not be possible

Design outcomes

Primary

MeasureTime frameDescription
Patient satisfactionWithin 1 week of completing asthma shared decision making app worksheet and their asthma clinic visitPatient satisfaction as determined by Patient Satisfaction Questionnaire responses. Questions will consist of the SDM-Q-9 (psychometrically validated measures for shared decision-making from the perspectives of patients), questions regarding satisfaction with content covered during the visit, and questions regarding satisfaction with the overall communication between the patient and physician.

Secondary

MeasureTime frameDescription
Physician satisfactionWithin 1 week of patient visitPhysician satisfaction as determined by Physician Satisfaction Questionnaire responses. Questions will consist of the SDM-Q-DOC (psychometrically validated measures for shared decision-making from the perspectives of health care providers), questions regarding satisfaction with content covered during the visit, and questions regarding satisfaction with the overall communication between the patient and physician. Physicians will receive a small number of satisfaction questionnaires, randomly assigned after patient visits, no more than one a week.
Change in level of asthma control will be determinedUp to 6 monthsChange in level of asthma control as determined by patient follow up asthma control test questionnaire responses regarding interval changes in asthma control, use of systemic steroids, and urgent care and emergency visits for asthma.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026